Tetrahydroquinoline morpholine compounds, compositions and use
US4782054A · kind A · utility
13Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 1988 |
| Grant date | Nov 1, 1988 |
| Priority date | — |
| Expiry date | Mar 4, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Morpholine compounds of the formula: ##STR1## in which R.sub.1 is hydrogen, straight-chain or branched (C.sub.1 -C.sub.6)-alkyl which may contain a double bond, aralkyl which may be substituted, (C.sub.5 -C.sub.6)-cycloalkyl or (C.sub.2 -C.sub.6)-acyl; and PA0 R.sub.2 is hydrogen, straight-chain or branched (C.sub.1 -C.sub.6)-alkyl which may contain a double bond, aralkyl which may be substituted, or (C.sub.2 -C.sub.3)-acyl; enantiomers and physiologically tolerable acid salts thereof. These compounds may be used therapeutically especially in the treatment of ischaemic syndromes and of cerebral ageing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.